$25.69
+0.335 (+1.32%)
At Close: Jun 04, 2026
Pfizer's Art Of The Deal
04:30pm, Wednesday, 01'st Oct 2025
President Trump and Pfizer announced a deal to cut drug pricing yeseterday. And it looks like the pharmaceutical giant got the better end of it.
All Cap Investing With Kirk Spano
03:20pm, Wednesday, 01'st Oct 2025
Kirk Spano runs Margin of Safety Investing and shares what this moment means for all cap investors. Stock picking and options strategies like covered calls and cash-secured puts to generate income and
This 6.75%-Yielding Dividend Stock Can Gain 33%
12:52pm, Wednesday, 01'st Oct 2025
Pfizer (NYSE:PFE) shares are finally starting to attract attention after gaining close to 7% in a single trading session on news that it's reached a pricing deal with the Trump administration.
Stock Of The Day: Will Pfizer Head Higher?
12:13pm, Wednesday, 01'st Oct 2025
Shares of Pfizer Inc. (NYSE:PFE) continue to head higher on Wednesday, a day after the company announced that it has secured a three-year grace period from President Donald Trump's tariffs on pharmac
Pfizer Just Announced a Massive Deal with TrumpRx. Here's What Investors Need to Know
11:42am, Wednesday, 01'st Oct 2025
Pfizer (PFE 5.53%) announced on Tuesday that it had signed an agreement with the White House that will help Americans pay lower prices for prescription drugs and bolster U.S. leadership in biopharmace
Pfizer's TrumpRx Pact Sends Shockwaves: Why UnitedHealth, Lilly And CVS Can't Look Away
10:49am, Wednesday, 01'st Oct 2025
Pfizer Inc's (NYSE:PFE) deal with Washington isn't just a handshake in the Oval Office — it's a seismic jolt to America's drug-pricing game. By agreeing to sell medicines on the government's new Tru
Pfizer Drug-Pricing Deal: More Upside For PFE Stock?
09:55am, Wednesday, 01'st Oct 2025
Pfizer stock (NYSE: PFE) offers a compelling investment opportunity at its current price of around $25, supported by attractive valuations and recent policy changes that may present further upside pot
Trump's pharmaceutical tariff threat loses bite after Pfizer deal reassures drugmakers
08:56am, Wednesday, 01'st Oct 2025
President Donald Trump's long-awaited threat to impose pharmaceutical tariffs may not pose as much of a challenge as drugmakers once feared, following his new drug-pricing deal with Pfizer. Trump's ag
Drug pricing, politics and the cost of doing business in the US
07:41am, Wednesday, 01'st Oct 2025
Drug pricing politics in Washington just took a sharp turn. Pfizer Inc (NYSE:PFE, ETR:PFE) has struck a deal with President Trump to support his “Most Favoured Nation” (MFN) plan, which links US
Pres. Trump's deal with Pfizer is pretty devastating to PBMs and insurance companies: John Lamattina
07:34am, Wednesday, 01'st Oct 2025
John Lamattina, PureTech Health senior partner and former Pfizer Global R&D president, joins 'Squawk Box' to discuss President Trump's deal with Pfizer, impact on drug prices, what the deal means for
Swiss pharma companies likely to follow Pfizer-U.S. price deal, says business lobby
07:09am, Wednesday, 01'st Oct 2025
Swiss pharma companies are likely to follow Pfizer's price deal with the U.S. following a demand from President Donald Trump's administration for lower drug prices, the head of a major Swiss chemical
WATERTOWN, Mass., Oct. 01, 2025 (GLOBE NEWSWIRE) -- C4 Therapeutics, Inc. (C4T) (Nasdaq: CCCC), a clinical-stage biopharmaceutical company dedicated to advancing targeted protein degradation science,
Got $200? 2 Healthcare Stocks to Buy and Hold Forever
05:10am, Wednesday, 01'st Oct 2025
You don't have to invest a fortune to get involved in an industry that could offer your portfolio growth along with safety. I'm talking about the field of healthcare, specifically companies that devel
3 Ultra-High-Yield Dividend Stocks -- Sporting an Average Yield of 9.5% -- Which Are No-Brainer Buys in October
03:51am, Wednesday, 01'st Oct 2025
For more than a century, the stock market has reigned supreme as the most-decorated wealth creator. No asset class has come close to matching the average annual return of stocks -- and with thousands
European healthcare stocks surge as U.S. Pfizer deal reduces some uncertainty
03:48am, Wednesday, 01'st Oct 2025
European healthcare stocks jumped on Wednesday, a day after Pfizer and U.S. President Donald Trump said the U.S.-based drugmaker agreed to lower prescription drug prices in the Medicaid program in exc
Sign In
Buy PFE